An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
KORU Medical Systems (NASDAQ: KRMD) will report Q4 and full year 2023 financial results on March 13, 2024. The company focuses on subcutaneous infusion solutions. A conference call and webcast will be held to discuss the results and provide a corporate update.
Positive
None.
Negative
None.
MAHWAH, N.J.--(BUSINESS WIRE)--
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous infusion solutions that improve quality of life for patients, today announced that the Company will report fourth quarter and full year 2023 financial results on Wednesday, March 13, 2024. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Conference Call and Webcast Details
The conference call can be accessed by dialing (844)-826-3035 for participants in the U.S. or Canada and (412)-317-5195 for international callers, using conference ID: 6447448. A live and archived webcast of the event can be accessed via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients around the world. The FREEDOM Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.
When will KORU Medical Systems report its Q4 and full year 2023 financial results?
KORU Medical Systems will report its Q4 and full year 2023 financial results on March 13, 2024.
What does KORU Medical Systems focus on?
KORU Medical Systems focuses on the development, manufacturing, and commercialization of innovative subcutaneous infusion solutions.
How can I access the conference call discussing the financial results?
The conference call can be accessed by dialing (844)-826-3035 for U.S. or Canada participants and (412)-317-5195 for international callers, using conference ID: 6447448.
Where can I find the archived webcast of the event?
The archived webcast can be accessed via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com for six months.
